Page last updated: 2024-08-17

cycloheximide and Cardiovascular Stroke

cycloheximide has been researched along with Cardiovascular Stroke in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Chen, L; Coffie, JW; Fang, L; Fang, Z; Gao, X; Li, C; Ma, L; Song, M; Wang, H; Wang, Q; Wang, S; Yang, W; Zhang, L1
Cai, SX; Drewe, J; Guastella, J; Huang, JC; Kasibhatla, S; Tran, M; Tseng, B; Wang, Y; Woodward, R; Xue, D; Yang, W; Zhang, L1
Koltai, M; Leprán, I; Szekeres, L1
Aksehirli, TO; Gaudette, GR; Krukenkamp, IB; Leavens, JE; Matsuyama, N; McKinnon, D1
Downey, JM; Liu, GS; Stanley, AW; Striplin, S; Swafford, A; Thornton, J; Van Winkle, DM1
Classen, HG; Solymoss, B; Varga, S1

Other Studies

6 other study(ies) available for cycloheximide and Cardiovascular Stroke

ArticleYear
Ferulic acid protects cardiomyocytes from TNF-α/cycloheximide-induced apoptosis by regulating autophagy.
    Archives of pharmacal research, 2020, Volume: 43, Issue:8

    Topics: Adenine; Animals; Apoptosis; Autophagy; Cell Line; Coumaric Acids; Cycloheximide; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocytes, Cardiac; Oxidative Stress; Rats; Reactive Oxygen Species; Tumor Necrosis Factor-alpha

2020
MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity.
    British journal of pharmacology, 2003, Volume: 140, Issue:2

    Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Brain Ischemia; Caspase 1; Caspase 3; Caspase Inhibitors; Caspases; Cycloheximide; Cysteine Proteinase Inhibitors; Dipeptides; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Female; HeLa Cells; Humans; Jurkat Cells; Liver; Male; Mice; Myocardial Infarction; Poly(ADP-ribose) Polymerases; Rats; Rats, Inbred F344; Tumor Necrosis Factor-alpha

2003
Effect of actinomycin D and cycloheximide on experimental myocardial infarction in rats.
    European journal of pharmacology, 1982, Jan-22, Volume: 77, Issue:2-3

    Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Cycloheximide; Dactinomycin; Dexamethasone; Drug Interactions; Male; Myocardial Infarction; Rats; Rats, Inbred Strains

1982
Ischemic but not pharmacological preconditioning requires protein synthesis.
    Circulation, 2000, Nov-07, Volume: 102, Issue:19 Suppl 3

    Topics: Action Potentials; Animals; Blood Flow Velocity; Blood Pressure; Coronary Vessels; Cycloheximide; Dactinomycin; Heart; Heart Function Tests; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; Organ Size; Pinacidil; Potassium Channels; Protein Biosynthesis; Protein Synthesis Inhibitors; Rabbits; Reperfusion Injury

2000
Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning.
    The American journal of physiology, 1990, Volume: 259, Issue:6 Pt 2

    Topics: Animals; Coronary Disease; Cycloheximide; Dactinomycin; Female; Heart; Male; Muscle Proteins; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Rabbits

1990
Aggravation of adrenergic cardiopathy by cyclohexylamine.
    Arzneimittel-Forschung, 1969, Volume: 19, Issue:11

    Topics: Adrenal Cortex Hormones; Aniline Compounds; Animals; Cycloheximide; Drug Synergism; Epinephrine; Female; Formaldehyde; Myocardial Infarction; Rats; Starvation; Stress, Physiological

1969